Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. ORCHID PHARMA GENNEX LAB./
ORCHID PHARMA
 
P/E (TTM) x 35.0 41.8 83.7% View Chart
P/BV x 4.5 7.7 58.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   ORCHID PHARMA
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
ORCHID PHARMA
Mar-23
GENNEX LAB./
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs9439 2.1%   
Low Rs5273 1.8%   
Sales per share (Unadj.) Rs3.4163.1 2.1%  
Earnings per share (Unadj.) Rs0.313.5 2.1%  
Cash flow per share (Unadj.) Rs0.327.0 1.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.5168.7 2.7%  
Shares outstanding (eoy) m176.6440.82 432.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.12.2 94.9%   
Avg P/E ratio x25.026.3 95.0%  
P/CF ratio (eoy) x21.013.2 159.4%  
Price / Book Value ratio x1.52.1 72.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,22914,522 8.5%   
No. of employees `000NANA-   
Total wages/salary Rs m79654 12.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5936,659 8.9%  
Other income Rs m40194 20.3%   
Total revenues Rs m6336,853 9.2%   
Gross profit Rs m471,235 3.8%  
Depreciation Rs m9548 1.7%   
Interest Rs m14329 4.1%   
Profit before tax Rs m64552 11.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m150-   
Profit after tax Rs m49552 8.9%  
Gross profit margin %7.918.5 42.6%  
Effective tax rate %22.80-   
Net profit margin %8.38.3 99.9%  
BALANCE SHEET DATA
Current assets Rs m4875,010 9.7%   
Current liabilities Rs m2953,719 7.9%   
Net working cap to sales %32.319.4 166.6%  
Current ratio x1.61.3 122.4%  
Inventory Days Days457 7.0%  
Debtors Days Days57,912,5891,180 4,909,735.2%  
Net fixed assets Rs m8357,242 11.5%   
Share capital Rs m180408 44.1%   
"Free" reserves Rs m6236,478 9.6%   
Net worth Rs m8046,886 11.7%   
Long term debt Rs m1631,488 10.9%   
Total assets Rs m1,32212,252 10.8%  
Interest coverage x5.72.7 213.0%   
Debt to equity ratio x0.20.2 93.8%  
Sales to assets ratio x0.40.5 82.6%   
Return on assets %4.77.2 66.0%  
Return on equity %6.18.0 76.3%  
Return on capital %8.010.5 76.0%  
Exports to sales %42.181.9 51.5%   
Imports to sales %13.637.6 36.2%   
Exports (fob) Rs m2505,452 4.6%   
Imports (cif) Rs m812,501 3.2%   
Fx inflow Rs m2505,452 4.6%   
Fx outflow Rs m862,726 3.2%   
Net fx Rs m1642,726 6.0%   
CASH FLOW
From Operations Rs m237183 129.1%  
From Investments Rs m-383-312 122.8%  
From Financial Activity Rs m210312 67.5%  
Net Cashflow Rs m64183 34.9%  

Share Holding

Indian Promoters % 23.6 69.8 33.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 18.6 -  
FIIs % 0.0 4.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 30.2 253.3%  
Shareholders   69,723 36,931 188.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs Orchid Pharma Share Price Performance

Period GENNEX LABORATORIES Orchid Pharma S&P BSE HEALTHCARE
1-Day 1.35% -0.40% 1.18%
1-Month -13.90% -14.06% -0.75%
1-Year 189.91% 173.54% 61.82%
3-Year CAGR 62.78% -23.64% 18.16%
5-Year CAGR 40.09% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.